Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Peptide fragment
Calcium channel blocker.
PDE5 inhibitor.
Serotonin/melatonin analog found in various pla...
NMDA potentiator, GABA-A antagonist.
Camptothecin analog; topoisomerase I inhibitor,...
Polyene, binds ergosterol and induces membrane ...
Stilbene, resveratrol analog.
Steroid hormone involved in stress signaling; g...
ITC, erysolin analog.
Aza-anthracenedione, DNA intercalator; topoisom...
Tetracycline; FIASMA, histamine H1, 5-HT2, mACh...
Triterpene sapogenin found in species of Panax;...
RAF inhibitor.
Heterocyclic light-emitting compound, natural l...
PKA substrate.
Non-selective cannabinoid receptor agonist.
Cannabinoid receptor 2 selective agonist.
Nedd8-activating enzyme inhibitor.
NSAID; COX-2 inhibitor.